Post Profile






Confusion over symptoms may be affecting whether women take tamoxifen for breast cancer

(Queen Mary University of London) Women who are at high risk of developing breast cancer may be failing to take the preventive anti-cancer drug tamoxifen because they are confusing naturally occurring symptoms with side effects from the medicine, according to a study of nearly 4,000 women led by Queen Mary University of London.
read more

share

Related Posts


Ability to Metabolize Tamoxifen Affects Breast Cancer Outcomes

Health : Newswise Medical News

For nearly a decade, breast cancer researchers studying the hormone therapy tamoxifen have been divided as to whether genetic differences in a liver enzyme affect the drug's effectiveness and the likelihood breast cancer will recur.

First Comprehensive Analysis Reveals Long-term Effectiveness Of SERMs For Preventing Breast Cancer

Health : Medical News Today

Selective oestrogen receptor modulators (SERMs: tamoxifen, raloxifene, arzoxifene, and lasofoxifene) significantly reduce the risk of developing the most common type of breast cancer among women at both high and average risk of the ...

Seasonal Effect Revealed For Tamoxifen In Breast Cancer Treatment

Health : Medical News Today

For women diagnosed with a form of breast cancer known as estrogen receptor positive (ER+) breast cancer, tamoxifen is an essential drug used in the treatment and prevention of recurring breast cancer. Currently, tamoxifen is used i...

Pronounced Reduction In Breast Density During Tamoxifen Treatment Reduces Risk Of Dying From Breast Cancer

Health : Medical News Today

Researchers at Karolinska Institutet have developed a method for assessing the effect of tamoxifen, a common drug to prevent the relapse of breast cancer. The key lies in monitoring changes in the proportion of dense tissue, which a...

Naturally occurring symptoms may be mistaken for tamoxifen side-effects

Health : EurekAlert: Health

(Cancer Research UK) Women taking tamoxifen to prevent breast cancer were less likely to continue taking the drug if they suffered nausea and vomiting, according to new data presented at the San Antonio Breast Cancer Symposium.

Comments


Copyright © 2016 Regator, LLC